StockClub

LGNZZ

LGNZZLigand Pharmaceuticals, Inc.$ --
Ligand Pharmaceuticals, Inc.

Ligand Pharmaceuticals, Inc.

LGNZZ

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
52M USD
YoY +14.1%
Operating Income
17M USD
YoY +148.0%
Net Income
-13M USD
YoY +68.6%
EPS
-0.67$
YoY +69.7%

Revenue

$51.7M
FY2024 Q2$72.5M
$72.5M
Q2
FY2024 Q3$124.3M
$124.3M
Q3
FY2024 Q4$167.1M
$167.1M
Q4
FY2025 Q1$45.3M
$45.3M
Q1
FY2025 Q2$93M
$93M
Q2
FY2025 Q3$208.4M
$208.4M
Q3
FY2025 Q4$268.1M
$268.1M
Q4
FY2026 Q1$51.7M
$51.7M
Q1
Actual
+$6.4M (+14.1%)

Net Income

$-13.3M
FY2024 Q2$34.2M
$34.2M
Q2
FY2024 Q3$27.1M
$27.1M
Q3
FY2024 Q4$-4M
$-4M
Q4
FY2025 Q1$-42.5M
$-42.5M
Q1
FY2025 Q2$-37.6M
$-37.6M
Q2
FY2025 Q3$79.7M
$79.7M
Q3
FY2025 Q4$124.5M
$124.5M
Q4
FY2026 Q1$-13.3M
$-13.3M
Q1
Actual
+$29.1M (+68.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$186.4M
FY2020
$186.4M
FY2021
Actual:$241.5M
FY2021
$241.5M
FY2022
Actual:$196.2M
FY2022
$196.2M
FY2023BEAT
Actual:$131.3M
Est:$128.9M
FY2023BEAT
$131.3M
FY2024BEAT
Actual:$167.1M
Est:$163.4M
FY2024BEAT
$167.1M
FY2025BEAT
Actual:$268.1M
Est:$264M
FY2025BEAT
$268.1M

Analyst Estimates